Lixte Biotechnology (LIXT) Q4 2022 Earnings

29MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.12
-0.11
-0.1
-0.09

Details

Expected EPS
N/A
Actual EPS
-0.1
Surprise EPS
-0.1
Surprise Percent
+∞%

Description

Lixte Biotechnology (LIXT) has reported earnings of -0.1 per share for Q4 2022.

0 Comments

Share your thoughts